...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
【24h】

Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.

机译:在长时间的PD停留期间,晶体(葡萄糖)和胶体(艾考糊精)渗透剂的组合显着增强了腹膜液和溶质的转运。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Fluid and sodium removal is often inadequate in peritoneal dialysis patients with high peritoneal solute transport rate, especially when residual renal function is declining. METHOD: We studied the effects of using simultaneous crystalloid (glucose) and colloid (icodextrin) osmotic agents on the peritoneal transport of fluid, sodium, and other solutes during 15-hour single-dwell exchanges using 3.86% glucose, 7.5% icodextrin, and a combination fluid with 2.61% glucose and 6.8% icodextrin in 7 prevalent peritoneal dialysis patients with fast peritoneal solute transport rate. RESULTS: The combination fluid enhanced net ultrafiltration (mean 990 mL) and sodium removal (mean 158 mmol) compared with 7.5% icodextrin (mean net ultrafiltration 462 mL, mean net sodium removal 49 mmol). In contrast, the 3.86% glucose-based solution yielded negligible ultrafiltration (mean -85 mL) and sodium removal (mean 16 mmol). The combination solution resulted in significantly improved urea (+41%) and creatinine (+26%) clearances compared with 7.5% icodextrin. CONCLUSION: A solution containing both crystalloid (glucose 2.61%) and colloid (icodextrin 6.8%) osmotic agents enhanced fluid removal by twofold and sodium removal by threefold compared with 7.5% icodextrin solution during a dwell of 15 hours, indicating that such a combination solution could represent a new treatment option for anuric peritoneal dialysis patients with high peritoneal solute transport rate.
机译:背景:在腹膜溶质转运率高的腹膜透析患者中​​,液体和钠的去除通常不足,尤其是当残余肾功能下降时。方法:我们研究了同时使用晶体(葡萄糖)和胶体(艾考糊精)渗透剂在3.85%葡萄糖,7.5%艾考糊精, 7例腹膜透析患者腹膜溶质转运速度快,联合使用含2.61%葡萄糖和6.8%艾考糊精的混合液。结果:相较于7.5%的艾考糊精(平均净超滤462 mL,平均净钠去除49 mmol),组合流体增强了净超滤(平均990 mL)和钠去除(平均158 mmol)。相比之下,基于3.86%葡萄糖的溶液产生的超滤(平均-85 mL)和钠去除(平均16 mmol)可忽略不计。与7.5%的艾考糊精相比,该组合溶液的尿素(+ 41%)和肌酐(+ 26%)清除率显着提高。结论:在15个小时的停留时间内,与7.5%的艾考糊精溶液相比,同时含有晶体(葡萄糖2.61%)和胶体(艾考糊精6.8%)渗透剂的溶液与7.5%的艾考糊精溶液相比,其液体去除率提高了两倍,钠去除率提高了三倍。可能是高腹膜溶质转运率的无尿腹膜透析患者的一种新的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号